UiPath (NYSE: PATH) GC & CLO reports 27,580-share sale under Rule 10b5-1
Rhea-AI Filing Summary
UiPath, Inc. insider transaction: The company’s General Counsel and Chief Legal Officer, Brad Brubaker, reported selling 27,580 shares of UiPath Class A common stock on 12/05/2025 at an average price of $18.5546 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule. Following this transaction, he beneficially owns 635,359 shares of UiPath Class A common stock, held directly.
Positive
- None.
Negative
- None.
Insights
Analyzing...
FAQ
What did UiPath (PATH) disclose in this Form 4 filing?
UiPath disclosed that its General Counsel and Chief Legal Officer, Brad Brubaker, sold 27,580 shares of Class A common stock on 12/05/2025 and now holds 635,359 shares directly.
At what price were the UiPath (PATH) shares sold in this insider transaction?
The reported average sale price was $18.5546 per share, with an overall transaction price range from $18.1700 to $18.8700.
Who is the reporting person in this UiPath (PATH) Form 4?
The reporting person is Brad Brubaker, who serves as UiPath’s General Counsel & Chief Legal Officer.
How many UiPath (PATH) shares does the insider own after the sale?
After the reported sale, Brad Brubaker beneficially owns 635,359 shares of UiPath Class A common stock in direct ownership form.
Was the UiPath (PATH) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states that the 27,580 shares were sold in compliance with a qualified selling plan adopted under Rule 10b5-1 under the Securities Exchange Act of 1934.
What price range did the UiPath (PATH) insider sale cover?
The filing explains that the transactions occurred in a price range from $18.1700 to $18.8700, and detailed trade data is available upon request.